CHRISTOPHER JOHN PITTENGER

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Pharmacological treatment of obsessive-compulsive disorder
    Christopher Pittenger
    Department of Psychiatry and Child Study Center, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA Electronic address
    Psychiatr Clin North Am 37:375-91. 2014
  2. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
  3. pmc Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
  4. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
  5. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011

Collaborators

Detail Information

Publications6

  1. pmc Pharmacological treatment of obsessive-compulsive disorder
    Christopher Pittenger
    Department of Psychiatry and Child Study Center, Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA Electronic address
    Psychiatr Clin North Am 37:375-91. 2014
    ..Proven second-line treatments include the tricyclic clomipramine and the addition of low-dose neuroleptic medications. OCD refractory to available treatments remains a profound clinical challenge. ..
  2. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
    ..If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy...
  3. pmc Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
    ....
  4. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
    ..Riluzole may hold promise for the treatment of several psychiatric conditions, possibly through its ability to modulate pathologically dysregulated glutamate levels, and merits further investigation...
  5. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011
    ....